Next Slideshow Title
Mayo Clinic: “High Cholesterol,” “Statin side effects: weigh the benefits and risks,” “Niacin can boost 'good' cholesterol.”
Harvard Health: “Why You May Need a Statin,” “Help for your cholesterol when the statins won't do,” “PCSK9 inhibitors: A major advance in cholesterol-lowering drug therapy,” “Managing statin muscle pain.”
CDC: “Cholesterol-lowering Medicine.”
American College of Cardiology: “High Triglycerides.”
American Heart Association: “Cholesterol Medications.”
International Journal of Clinical Practice: “Ezetimibe-associated adverse effects: what the clinician needs to know.”
World Journal of Cardiology: “PCSK9 Inhibitors: a new era of lipid lowering therapy.”
American Family Physician: “Management of Hypertriglyceridemia.”
Expert Opinions in Investigative Drugs: “Evaluating bempedoic acid for the treatment of hyperlipidaemia.”
European Society of Cardiology: “Inclisiran lowers 'bad' cholesterol for up to one year (ORION 1).”
Medscape: “PCSK9 Inhibitors: How They Work and Who Should Get Them.”
NIH LiverTox: “Ezetimibe.”
Reviewed by Sabrina Felson, MD on January 22, 2020
This tool does not provide medical advice. See additional information.
THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.